Hongwei Wang

Title: Innovations of Hongwei Wang in Cell Line Development

Introduction

Hongwei Wang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of cell lines for research and application.

Latest Patents

Wang holds a patent titled "Establishment and suspension acclimation of CRFK adherent cell line, and its application." This patent details the establishment and suspension acclimation of a Crandell Reese Feline Kidney (CRFK) adherent cell line, specifically named CRFK-BLA. This cell line has been deposited at the China General Microbiological Culture Collection Center (CGMCC) under the deposit number CGMCC NO: 45703. Additionally, a serum-free complete suspension culture type CRFK cell line, named CRFK-BLS, has also been developed and deposited at the same center with the deposit number CGMCC NO: 45704.

Career Highlights

Wang is currently employed at Taizhou Bioally Technology Co., Ltd., where he continues to innovate in the field of biotechnology. His work focuses on the development of cell lines that can be utilized in various applications, enhancing research capabilities in the life sciences.

Collaborations

Wang collaborates with notable colleagues, including Wenda Shi and Hao Dong, who contribute to his research and development efforts.

Conclusion

Hongwei Wang's contributions to the field of biotechnology, particularly through his patented innovations in cell line development, highlight his role as a significant inventor in this domain. His work continues to impact research and applications in the life sciences.